Sage Therapeutics Inc (SAGE)
6.31
-0.01
(-0.16%)
USD |
NASDAQ |
Nov 08, 11:31
Sage Therapeutics Revenue (TTM): 106.40M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 106.40M |
| June 30, 2024 | 97.24M |
| March 31, 2024 | 91.06M |
| December 31, 2023 | 86.46M |
| September 30, 2023 | 11.35M |
| June 30, 2023 | 10.37M |
| March 31, 2023 | 9.399M |
| December 31, 2022 | 7.687M |
| September 30, 2022 | 6.464M |
| June 30, 2022 | 6.165M |
| March 31, 2022 | 6.307M |
| Date | Value |
|---|---|
| December 31, 2021 | 6.308M |
| September 30, 2021 | 1.114B |
| June 30, 2021 | 1.114B |
| March 31, 2021 | 1.113B |
| December 31, 2020 | 1.114B |
| September 30, 2020 | 6.974M |
| June 30, 2020 | 8.905M |
| March 31, 2020 | 8.689M |
| December 31, 2019 | 6.868M |
| September 30, 2019 | 5.181M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
6.165M
Minimum
Jun 2022
1.114B
Maximum
Dec 2020
246.61M
Average
9.886M
Median
Revenue (TTM) Benchmarks
| Outset Medical Inc | 114.73M |
| Biogen Inc | 9.608B |
| Johnson & Johnson | 87.70B |
| Lifecore Biomedical Inc | 128.44M |
| Organon & Co | 6.409B |